Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593892 · ClinicalTrials.gov registry record
Inflammatory Cytokine Variations in Traumatic Injury Responses
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 90
- Enrollment target
NCT00593892: Completed study, sponsored by University of Alabama at Birmingham.
NCT00593892 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00593892 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the type of surgery (orthopaedic, general surgery, thoracic, etc.) affects the level of cytokines and thus potentially the risk of multisystem organ failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-06 |
What the finished NCT00593892 record still lists
NCT00593892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00593892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00593892 about?
NCT00593892 is a clinical study titled "Inflammatory Cytokine Variations in Traumatic Injury Responses". The purpose of this study is to determine if the type of surgery (orthopaedic, general surgery, thoracic, etc.) affects the level of cytokines and thus potentially the risk of multisystem organ failure.
What is the current status of trial NCT00593892?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2007-05. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00593892?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia